Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
07/2011
07/07/2011US20110165076 Novel [f-18]- labelled l-glutamic acid and l-glutamine derivatives (i), use thereof and method for their production
07/07/2011US20110165075 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
07/07/2011US20110165074 Chelating amphiphilic polymers
07/07/2011US20110165073 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
07/07/2011US20110165072 Detection of Early-Stage Pancreatic Adenocarcinoma
07/07/2011US20110165071 Methods Of Treating Cancer
07/07/2011US20110165070 Methods for radiolabeling synthetic polymers
07/07/2011US20110165069 Methods for radiolabeling macromolecules
07/07/2011US20110165068 Liposome medicament, method of preparation and use thereof
07/07/2011US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
07/07/2011US20110165066 Interleukin-13 binding proteins
07/07/2011US20110165065 Means for the detection and treatment of prostate cells
07/07/2011US20110165064 Methods and compositions related to clot-binding compounds
07/07/2011US20110165063 Il-1 binding proteins
07/07/2011US20110165062 Use of an anti-cd151 antibody for early treatment of cancer
07/06/2011EP2340041A2 Porphyrazine optical and dual optical/mr contrast and therapeutic agents
07/06/2011EP1588145B1 Methods, mixtures, kits and compositions pertaining to analyte determination
07/06/2011CN102115474A Novel <18>F-marked pyrazolo[1,5-a]pyrimidine compound and preparation and application thereof
07/05/2011US7972588 Radiolabelling methods
07/05/2011CA2482327C Pendant fatty acid imaging agents
07/05/2011CA2453845C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
07/05/2011CA2439099C Anti-platelet and anti-thrombotic agents
07/05/2011CA2373901C Sterile radioactive seeds
06/2011
06/30/2011WO2011078250A1 Radiolabeled compound directable in vivo to target tissue and use thereof
06/30/2011WO2011077751A1 Composition for labeling tissues of central nervous system, method for labeling tissues of central nervous system, and screening method using the composition for labeling tissues of central nervous system
06/30/2011WO2011077733A1 Transnasal labeling composition for tissues of central nervous system, and labeling method and screening method each using the transnasal labeling composition for tissues of central nervous system
06/30/2011WO2011076825A1 Formulations suitable for pet imaging with hydrophobic pet agents
06/30/2011WO2011076803A1 Measuring device and method for analysing a test gas by means of an infrared absorption spectroscopy
06/30/2011WO2011041319A3 Specific binding proteins and uses thereof
06/30/2011WO2011033112A3 68ga-labeled human serum albumin
06/30/2011US20110159525 Methods to determine immunogenicity of humanized anti-tag 72 cc49 antibodies
06/30/2011US20110158907 Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques
06/30/2011US20110158906 Targeted block copolymer micelles
06/30/2011US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use
06/30/2011US20110158904 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
06/30/2011US20110158903 One pot processes of preparing multifunctional liposome drug for imaging, delivery and targeting in cancer diagnosis and therapy
06/30/2011US20110158902 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
06/30/2011US20110158901 Chitosan-based nanoparticles and methods for making and using the same
06/30/2011DE102009060317A1 Tracking von Knochenmarkzellen für das Metastasenscreening Tracking of bone marrow cells for metastasis screening
06/30/2011DE102009055321A1 Verfahren zur Bestimmung der Leberleistung eines Lebewesens mittels quantitativer Messung der Metabolisierung von Substraten A method of determining the liver function of a living being by means of quantitative measurement of the metabolism of substrates
06/30/2011CA2785576A1 Formulations suitable for pet imaging with hydrophobic pet agents
06/30/2011CA2785489A1 Measuring device and method for analysing a test gas by means of an infrared absorption spectroscopy
06/29/2011EP2338892A1 Prostate specific membrane antigen inhibitors
06/29/2011EP2338525A2 Remote detection of substance delivery to cells
06/29/2011EP2338479A1 Radioactively marked microparticles, method for their manufacture and application thereof
06/29/2011CN101555263B D-glucose dithiocarbamate complex marked by <99m>TcO, preparation method and applications thereof
06/28/2011US7968511 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
06/28/2011US7968129 Cosmetic skin care complex with anti-aging effect
06/28/2011US7968081 Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof
06/28/2011US7968080 Somatostatin analogs with inhibitory activity to growth hormone release
06/28/2011CA2505142C Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
06/28/2011CA2483181C Method for obtaining a 2-18f-fluor-2-deoxy-d-glucose (18f-fdg) - solution
06/28/2011CA2464002C Pacap compositions and methods for tumor imaging and therapy
06/28/2011CA2259944C Melanoma associated peptide analogues and vaccines against melanoma
06/23/2011WO2011073340A1 Labelled integrin binders
06/23/2011WO2011073304A1 Aryloxyanilide imaging agents
06/23/2011WO2011073286A1 Prostate specific membrane antigen inhibitors
06/23/2011WO2011044410A3 Solid phase extraction purification method
06/23/2011WO2011044406A3 Purification method
06/23/2011WO2011017456A3 Localized delivery of nanoparticles for therapeutic and diagnostic applications
06/23/2011US20110152193 Inhibitors of human plasmin derived from the kunitz domains
06/23/2011US20110150938 Supercrystalline Colloidal Particles and Method of Production
06/23/2011US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging
06/23/2011US20110150765 Frozen compositions and methods for piercing a substrate
06/23/2011US20110150764 Stroke-tageting peptide and use thereof
06/23/2011US20110150763 Triazine derivatives and their therapeutical applications
06/23/2011US20110150762 Bone cement containing bone marrow
06/23/2011US20110150760 PRLR-Specific Antibody and Uses Thereof
06/23/2011US20110150759 Monoclonal antibody 175 tageting the egf receptor and derivatives and uses thereof
06/23/2011US20110150758 Tracking of bone marrow cells for metastasis screening
06/23/2011US20110150757 Compounds for inhibiting ksp kinesin activity
06/23/2011CA2785064A1 Prostate specific membrane antigen inhibitors
06/22/2011EP2336192A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
06/22/2011EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
06/22/2011EP2336185A1 Anti- alpha v beta 6 antibodies
06/22/2011EP2335739A1 Molecular probe precursor for imaging of pancreatic islet, and use thereof
06/22/2011EP2335728A1 Specific binding proteins and uses thereof
06/22/2011EP2334181A1 Phthalimide derivative metabotropic glutamate r4 ligands
06/22/2011EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
06/22/2011CN102105174A Diagnostic agents selective against metalloproteases
06/22/2011CN102100918A Evaluation method for disintegration dynamics process in plant shell vacant capsule
06/22/2011CN101670120B Drug for diagnosis of gastric cancer and preparation method thereof
06/22/2011CN101198359B Radioactive diagnostic imaging agent
06/21/2011US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease
06/21/2011US7964644 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means
06/21/2011US7964556 Antimicrobial peptides and use thereof
06/21/2011US7964555 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions
06/16/2011WO2011071083A1 Molecular probe for imaging of pancreatic islet, and use thereof
06/16/2011WO2011070136A1 Iodine radiolabelling method
06/16/2011WO2011070066A1 Fty720 halogenated derivatives
06/16/2011WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof
06/16/2011WO2011044422A3 Solid phase extraction purification method
06/16/2011US20110144483 Imaging agents
06/16/2011US20110142760 Psma-binding agents and uses thereof
06/16/2011US20110142759 Agents and methods for the imaging of myelin basic protein
06/16/2011US20110142758 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods
06/16/2011US20110142757 Novel compounds and their uses in diagnosis
06/16/2011US20110142756 Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer
06/16/2011CA2780859A1 Fty720 halogenated derivatives
06/15/2011EP2332576A1 Immunotherapy of B-cell malignancies using anti-CD22 antibody conjugates
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 243